SoVote

Decentralized Democracy

House Hansard - 75

44th Parl. 1st Sess.
May 19, 2022 10:00AM
Context: House Hansard - 75 - May/19/22
Mrs. Marie-France Lalonde (Orléans, Lib.)
  • May/19/22 2:01:35 p.m.
  • Watch
Madam Speaker, last week I met with representatives of Nova Oculus, a Canadian company that has developed a promising new medical device to treat age-related macular degeneration, or AMD. This incurable disease is the leading cause of blindness for more than two million Canadians over the age of 50. Nova Oculus is currently awaiting regulatory approval from Health Canada for a new form of AMD treatment that uses microcurrent technology in a waveform applied directly to the retina. In the recently completed clinical trials, participants saw immediate results and optimal visual improvement after just four four-minute treatments. They saw improvements in their ability to watch television, recognize faces and function in their environment. Our government recognizes that one of the most important issues affecting seniors is when they cannot remain in their homes and maintain a good quality of life. That is why I commend Nova Oculus for its passion and determination to give Canadian seniors with AMD the ability to improve their vision and enjoy the golden years of their lives.
175 words
  • Hear!
  • Rabble!
  • star_border